A5082083207- Pharmaceutical Practices and Patient Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Frailty in Older Adults
- Medication Adherence and Compliance
- Prostate Cancer Treatment and Research
- Palliative Care and End-of-Life Issues
- Nutrition and Health in Aging
- Cardiac, Anesthesia and Surgical Outcomes
- Chronic Disease Management Strategies
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
- Estrogen and related hormone effects
- Pharmacy and Medical Practices
- Cancer-related cognitive impairment studies
- Diabetes Management and Education
- Cardiac pacing and defibrillation studies
- Pharmaceutical studies and practices
- Intensive Care Unit Cognitive Disorders
- Analytical Methods in Pharmaceuticals
- Potassium and Related Disorders
- Cancer, Lipids, and Metabolism
- Nausea and vomiting management
- Cardiac electrophysiology and arrhythmias
- Lymphoma Diagnosis and Treatment
- Chemotherapy-induced cardiotoxicity and mitigation
Thomas Jefferson University
2014-2023
Jefferson College of Health Sciences
2016-2023
Jefferson College
2015-2023
Fox Chase Cancer Center
2023
GTx (United States)
2023
Sidney Kimmel Cancer Center
2019
Thomas Jefferson University Hospital
2019
Memorial Sloan Kettering Cancer Center
2017
University of Maryland, Baltimore
2012-2016
Brentwood Hospital
1938-1940
Purpose The use of multiple and/or inappropriate medications in seniors is a significant public health problem, and cancer treatment escalates its prevalence complexity. Existing studies are limited by patient self-report medical record extraction compared with pharmacist-led comprehensive medication assessment. Patients Methods We retrospectively examined ambulatory senior adults to determine the polypharmacy (PP) potentially (PIM) associated factors. PP was defined as concurrent five or...
Polypharmacy is prevalent in older adults with cancer and may be advantageous for the management of certain chronic disease states, but uncertainty exists regarding potential hazards consequences. Cancer-related therapy adds to prevalence polypharmacy, which can lead compromised plans (i.e., postoperative complications, treatment delays, and/or premature discontinuation). has been identified as one domains commonly included Comprehensive Geriatric Assessment likely because influence on...
Background: Polypharmacy and potentially inappropriate medications (PIMs) are prevalent in older adults with cancer, but their associations physical function not often studied. This study examined the of polypharmacy PIMs determined optimal cutoff value for number most strongly associated functional impairment. Methods: cross-sectional analysis used baseline data from a randomized enrolling patients aged ≥70 years advanced cancer starting new systemic treatment. We categorized PIM using 2015...
This paper is an attempt to record the experience gained in treating 44 schizophrenics this hospital with cardiazol from September, 1937, when treatment was first used, middle of April, 1938.